Digang, Rowena .
HRN: 23-99-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2023
AMPICILLIN 1GM (VIAL)
11/19/2023
11/26/2023
IV
2gm
Q6
Thinly Meconium Stained Amniotic Fluid
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes